Glaxosmithkline Pharmaceuticals Ltd KYS Report: Ownership & Insights

GlaxoSmithKline Pharmaceuticals Ltd. Know Your Stock

NSE BSE

15:58 Jul 18

GlaxoSmithKline Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

3138.40

-35.20 (-1.11%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

GlaxoSmithKline Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:58 Jul 18

3138.40

-35.20 (-1.11%)

79/100 High Financial Strength

Quality

34/100 Mid Valuation

Valuation

55/100 Technically Neutral

Technical

SWOT

Strength

Weakness

Opportunity

Threat

53.17K

Market Cap (Cr)

57.32

PE Ratio

27.25

Price to Book Ratio

40.81

RSI

24.81 %

Net Profit Margin

Rating Based on 2 Analysts

Buy 0%

Hold 50%

Sell 50%

Hold

The consensus recommendation from 1 analysts for GlaxoSmithKline Pharmaceuticals Ltd. is Hold

Analyst Price Target

The average price target is 2610 with a high estimate of 2620 and low estimate of 2600

High Average Low

Current 3138.40

2620.00

2610.00

2600.00

Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

Strength Weakness Opportunity Threats

Download Our App On: